Our lab created a humanized aromatase mouse model (Aromhum) that recapitulates this phenotype in the LAM and highlights the importance of estradiol (E2) action in LAM fibrosis and atrophy (12). Here, CYP19A1 is linked to lymphangioleiomyomatosis.